Affordable Access

Candesartan cilexetil: an angiotensin II receptor blocker.

Authors
Type
Published Article
Journal
The Annals of Pharmacotherapy
1060-0280
Publisher
SAGE Publications
Publication Date
Volume
33
Issue
12
Pages
1287–1298
Identifiers
PMID: 10630830
Source
Medline

Abstract

Candesartan cilexetil provides an alternative antihypertensive therapy that is well tolerated and effective in reducing blood pressure in a wide range of patients. Due to its greater binding affinity to the angiotensin II receptor, candesartan cilexetil appears to have a longer antihypertensive effect than losartan. This may be advantageous in decreasing morbidity and mortality associated with hypertension, although further studies are required to validate this potential advantage.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F